Walter and Eliza Hall Institute

A new discovery around inflammation and excessive cell death in the body illuminates the key role a certain enzyme plays in the process, and how targeting a "sugar tag" could lead to treatments for a wide range of conditions.

A new understanding of the way the body teaches immune cells to fight off threats has raised hopes of advanced treatments for autoimmune conditions such as multiple sclerosis, along with other diseases such as cancer.

For around a decade, scientists researching Parkinson's disease have been probing a pathway involved in the way brain cells process energy, and now a mystery around the role of a particular protein has been solved thanks to a new live action view.

People with chronic respiratory disease tend to produce thicker forms of mucus and scientists have now uncovered one of the key reasons why, raising new treatment possibilities for conditions like asthma, cystic fibrosis and COPD.

New research into CAR-T cell therapy has revealed crucial mechanisms that could help the immunotherapy technique, which is currently only effective against blood cancers, be adapted for the treatment of brain tumors and other forms of solid cancers.

Using an advanced imaging technique, scientists have watched as treatment-resistant leukemia cells teased chemotherapy into a high-stakes game of tag, an observation that opens up new ways in which we may be able to stop the deadly disease in its tracks. ​​

Scientists have discovered a fast-acting insulin from a notoriously slow-moving source, finding the insulin in a certain type of snail venom can begin working in a third of the time of the fastest insulins currently on the market. ​

Australian researchers have discovered a protein that facilitates the spread of acute myeloid leukaemia cells, and have shown that by blocking its activity they can stop the deadly form of cancer in its tracks.

Scientists have developed a new drug-like molecule with the ability to inhibit a key signal that triggers inflammation in the body. The scientists say the molecule has already shown promise for putting the brakes on the progression of multiple sclerosis (MS).

Researchers have solved the mystery as to how insulin binds to the insulin receptor on the surface of cells, offering the potential for the development of new and improved insulin medications to treat type 1 and type 2 diabetes.